Blog
Alzheimers vs Type 3
The Metabolic Side of Alzheimer’s Disease
Kirsten Hobson, B.S.
Physician Reviewed
What Is Type 3 Diabetes?
Type 3 diabetes, an unofficial diagnosis, refers to insulin resistance occurring specifically within the brain. In healthy neurons, insulin activates pathways that help cells use energy, repair themselves, and maintain communication between synapses. In Type 3 diabetes, insulin signaling becomes impaired, glucose metabolism declines, and neurons struggle to generate enough energy.
Researchers describe this as a “brain energy crisis.” As neurons lose access to efficient fuel sources, inflammation increases, toxic proteins accumulate, and brain cells become more vulnerable to degeneration.
Although researchers do not claim Alzheimer’s is synonymous with diabetes, the similarities between insulin resistance and metabolic dysfunction have led many scientists to view Alzheimer’s as partly a metabolic disease of the brain.
What Is Insulin and Why Does the Brain Need It?
Insulin is a hormone that helps regulate blood sugar by moving glucose into cells for energy. Think of glucose as fuel, cells as cars, and insulin as the key that allows fuel into the engine. Without insulin functioning properly, cells struggle to produce energy efficiently.
The brain depends heavily on glucose because neurons require enormous amounts of energy to support memory, learning, and communication. Insulin helps neurons regulate glucose use, maintain energy balance, and support mitochondrial function.
When insulin signaling weakens, neurons become less efficient at using fuel, even if blood sugar levels remain normal. Over time, this can create metabolic stress inside the brain.
What Is Alzheimer’s Disease?
Traditionally, Alzheimer’s disease has been defined by amyloid-beta plaques, tau tangles, and progressive neuron loss. Amyloid plaques accumulate outside neurons and disrupt communication between brain cells, while tau tangles damage the internal structure of neurons and eventually lead to cell death.
As the disease progresses, synapses weaken, neurons die, and brain tissue shrinks particularly in areas responsible for memory and reasoning, such as the hippocampus and cortex.
The Brain’s Energy and Insulin Signaling Breakdown
Research suggests the link between insulin and Alzheimer’s is not just about blood sugar, but about how insulin behaves inside the brain itself. Studies show that insulin must be actively transported across the blood–brain barrier, and this transport system can become less efficient with aging, obesity, and neurodegeneration.
Once inside the brain, insulin acts as a signaling molecule that supports neuronal survival, synaptic function, and energy regulation. However, new evidence suggests that in Alzheimer’s disease, neurons become less responsive to insulin signaling, meaning the brain is no longer able to properly “hear” insulin’s metabolic instructions.
At the same time, imaging and biochemical studies show reduced glucose metabolism in the Alzheimer’s brain, even in early stages of disease. This indicates that neurons are not efficiently converting glucose into usable energy, creating what researchers call a progressive energy deficit.
Together, these findings suggest Alzheimer’s involves a breakdown in three connected systems: insulin transport into the brain, insulin signaling within neurons, and glucose utilization for energy. This combined dysfunction is what supports the “Type 3 diabetes” hypothesis as a metabolic framework for understanding neurodegeneration.
How Does Insulin Reach the Brain?
The brain is protected by the blood-brain barrier (BBB), which prevents many substances from freely entering brain tissue. Because of this barrier, insulin cannot cross into the brain on its own.
Instead, insulin enters through a tightly regulated process called receptor-mediated transcytosis. Insulin binds to transport-related receptors on blood vessel cells, is carried through the barrier in small vesicles, and is then released into the brain.
A simple way to think about the BBB is like airport security. Most substances cannot pass freely, so insulin requires a specialized checkpoint and transport system.
When this system becomes impaired, less insulin reaches the brain, neurons become metabolically stressed, and cognitive function may decline over time. Researchers believe this disruption may occur in obesity, Type 2 diabetes, aging, and Alzheimer’s disease.
How Is Alzheimer’s Connected to Metabolism?
Recent studies suggest Alzheimer’s may involve metabolic dysfunction long before noticeable memory symptoms appear. Researchers have found reduced brain glucose metabolism, impaired mitochondrial function, insulin resistance, and chronic inflammation in many Alzheimer’s patients.
In simple terms, the brain begins struggling to fuel itself properly. Since neurons require large amounts of energy, impaired glucose use can weaken communication between cells, reduce the brain’s ability to repair itself, and contribute to the buildup of amyloid plaques and tau tangles.
Still, Alzheimer’s remains a complex disease influenced by many factors, including aging, genetics, inflammation, vascular dysfunction, oxidative stress, and metabolic health. The Type 3 diabetes theory is not meant to replace traditional Alzheimer’s research, but rather expand our understanding of how metabolism may contribute to neurodegeneration.
Frequently Asked Questions (FAQ’s)
Does high blood sugar cause Alzheimer’s disease?
Not directly. However, metabolic disorders such as diabetes and insulin resistance are associated with a higher risk of cognitive decline and Alzheimer’s-related changes.
Can insulin resistance happen in the brain?
Yes. Research suggests neurons can become less responsive to insulin signaling, which may affect how the brain uses glucose and maintains energy balance.
References:
Atabi F, Moassesfar M, Nakhaie T, Bagherian M, Hosseinpour N, Hashemi M. A systematic review on type 3 diabetes: bridging the gap between metabolic dysfunction and Alzheimer's disease. Diabetol Metab Syndr. 2025 Aug 27;17(1):356. doi: 10.1186/s13098-025-01930-2. PMID: 40859375; PMCID: PMC12382249.
Gray SM, Meijer RI, Barrett EJ. Insulin regulates brain function, but how does it get there? Diabetes. 2014 Dec;63(12):3992-7. doi: 10.2337/db14-0340. PMID: 25414013; PMCID: PMC4237995.
Kciuk M, Kruczkowska W, Gałęziewska J, Wanke K, Kałuzińska-Kołat Ż, Aleksandrowicz M, Kontek R. Alzheimer's Disease as Type 3 Diabetes: Understanding the Link and Implications. Int J Mol Sci. 2024 Nov 7;25(22):11955. doi: 10.3390/ijms252211955. PMID: 39596023; PMCID: PMC11593477.
Rhea EM, Rask-Madsen C, Banks WA. Insulin transport across the blood-brain barrier can occur independently of the insulin receptor. J Physiol. 2018 Oct;596(19):4753-4765. doi: 10.1113/JP276149. Epub 2018 Aug 28. PMID: 30044494; PMCID: PMC6166047.
Medical Advice Disclaimer
The content on CMS’s website (including, without limitation, any testimonials) is for general informational purposes only. It is not intended to diagnose or treat any condition, illness, or disease. All content from this site or connected social media channels is not intended to be used for medical diagnosis or treatment. Please consult a licensed medical professional for medical advice. CMS does not guarantee the accuracy, completeness, or timeliness of any information presented on this website.
